PulseExploreJournal ClubResearchersJournals
Instagram
HomeJournal ClubExplore
Synapse
⌘+K
Synapse
August 1, 2025Clinical and Applied Thrombosis/HemostasisOpen Access

Anticoagulation Control and Associated Factors in Patients with Atrial Fibrillation Receiving Warfarin at a Tertiary Care Hospital in Nepal

View Full Paper
Ask AI
Bookmark
Share

Authors

RAR K AdhikariSSShiv Kumar SahRGRatna Mani Gajurel

Discussion

Loading...

Member takes

Overview

Cross-sectional study assesses anticoagulation control in atrial fibrillation patients receiving warfarin, highlighting factors influencing therapeutic outcomes.

Key Points

  • Only 30.6% of atrial fibrillation patients achieved optimal anticoagulation control with warfarin.
  • The mean Time in Therapeutic Range among participants was recorded at 40.14%, indicating suboptimal management.
  • The analysis identified female gender and longer therapy duration as factors associated with better anticoagulation control.
  • Further investigation is warranted to understand the low therapeutic levels in warfarin-treated patients, emphasizing regular monitoring.

Cite This Study

Adhikari et al. (2025) studied this question.

synapsesocial.com/papers/68af7e047567bf4f94ff581chttps://doi.org/10.1177/10760296251371047
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched one closely related paper. Consider it for comparative context:

  1. 1How to Calculate Sample Size for Different Study Designs in Medical Research?2013 · 3,503 citations